Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Becton Dickinson and Co stock

BDX
US0758871091
857675

Price

0
Today +/-
-0
Today %
-0 %

Becton Dickinson and Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Becton Dickinson and Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Becton Dickinson and Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Becton Dickinson and Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Becton Dickinson and Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Becton Dickinson and Co Stock Price History

DateBecton Dickinson and Co Price
12/23/20240 undefined
12/23/20240 undefined
12/20/20240 undefined
12/19/20240 undefined
12/18/20240 undefined
12/17/20240 undefined
12/16/20240 undefined
12/13/20240 undefined
12/12/20240 undefined
12/11/20240 undefined
12/10/20240 undefined
12/9/20240 undefined
12/6/20240 undefined
12/5/20240 undefined
12/4/20240 undefined
12/3/20240 undefined
12/2/20240 undefined
11/29/20240 undefined
11/27/20240 undefined
11/26/20240 undefined
11/25/20240 undefined

Becton Dickinson and Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Becton Dickinson and Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Becton Dickinson and Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Becton Dickinson and Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Becton Dickinson and Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Becton Dickinson and Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Becton Dickinson and Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Becton Dickinson and Co’s growth potential.

Becton Dickinson and Co Revenue, EBIT and net profit per share

DateBecton Dickinson and Co RevenueBecton Dickinson and Co EBITBecton Dickinson and Co Net Income
2028e0 undefined0 undefined0 undefined
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
20240 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined

Becton Dickinson and Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e
0000000000000000000000000000000000000000000000
----------------------------------------------
----------------------------------------------
0000000000000000000000000000000000000000000000
0000000000000000000000000000000000000000000000
----------------------------------------------
0000000000000000000000000000000000000000000000
----------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Becton Dickinson and Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Becton Dickinson and Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                                   
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
                                                                                   
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
000000000000000000000000000000000000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Becton Dickinson and Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Becton Dickinson and Co's financial health and stability.

Assets

Becton Dickinson and Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Becton Dickinson and Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Becton Dickinson and Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Becton Dickinson and Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
--------------------------------------
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000

Becton Dickinson and Co stock margins

The Becton Dickinson and Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Becton Dickinson and Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Becton Dickinson and Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Becton Dickinson and Co's sales revenue. A higher gross margin percentage indicates that the Becton Dickinson and Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Becton Dickinson and Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Becton Dickinson and Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Becton Dickinson and Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Becton Dickinson and Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Becton Dickinson and Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Becton Dickinson and Co Margin History

Becton Dickinson and Co Gross marginBecton Dickinson and Co Profit marginBecton Dickinson and Co EBIT marginBecton Dickinson and Co Profit margin
2028e0 %0 %0 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
20240 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %

Becton Dickinson and Co Stock Sales Revenue, EBIT, Earnings per Share

The Becton Dickinson and Co earnings per share therefore indicates how much revenue Becton Dickinson and Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Becton Dickinson and Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Becton Dickinson and Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Becton Dickinson and Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Becton Dickinson and Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Becton Dickinson and Co Revenue, EBIT and net profit per share

DateBecton Dickinson and Co Sales per ShareBecton Dickinson and Co EBIT per shareBecton Dickinson and Co Earnings per Share
2028e0 undefined0 undefined0 undefined
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
20240 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined

Becton Dickinson and Co business model

Becton Dickinson and Co (BD) is an American company specializing in medical devices and accessories. It was founded in 1897 in New Jersey and since then has had a long history as an innovator in the healthcare industry. BD's business model is to manufacture and distribute medical devices and accessories for various applications. The company offers a wide range of products, including syringes, needles, catheters, infusion sets, blood diagnostic products, serum samples, tumor analysis devices, sterilization equipment, and more. BD is also a major provider of medical devices and accessories for diabetes management, including insulin pumps, lancets, test strips, and other products. BD operates in three main segments: Medical Devices, Diagnostics, and Life Sciences. In the Medical Devices segment, BD develops, manufactures, and distributes medical products such as syringes, needles, catheters, implants, and surgical instruments. This segment accounts for the largest portion of revenue, as BD's products are widely used in hospitals and other medical facilities worldwide. In the Diagnostics segment, BD offers products and services for the diagnosis of various diseases, particularly in the field of infectious diseases. Here, the company is a leader in the development of tests and instruments for the detection of HIV, hepatitis B and C, tuberculosis, and other infections. BD's Life Sciences segment produces and distributes devices and reagents for research and development, particularly in the areas of cell analysis, genomics, and proteomics. The company works closely with academics, researchers, and the pharmaceutical industry to develop innovative solutions that can contribute to the discovery of new therapies. BD is known for its long-standing experience in healthcare, its deep industry knowledge, and its efforts to develop new technologies and products that can improve people's lives. BD's products are manufactured and distributed in the United States and in more than 50 countries worldwide. Some of BD's most popular products include insulin pumps, syringes and needles, automated infusion systems, blood testing materials, and tumor diagnosis devices. In recent times, due to the pandemic, BD has also invested heavily in the development of test kits and protective clothing, thereby adapting part of its business model to the COVID-19 crisis. Overall, BD is a leading company in the medical and healthcare industry, characterized by its long history, comprehensive range of medical devices, and innovative power. With a strong focus on quality and customer satisfaction, BD remains an important provider of healthcare products and services in the healthcare industry. Becton Dickinson and Co is one of the most popular companies on Eulerpool.com.

Becton Dickinson and Co SWOT Analysis

Strengths

1. Market leader: Becton Dickinson (BD) is a well-established and recognized company with a significant market share in the medical technology industry.

2. Diverse product portfolio: BD offers a wide range of medical devices, diagnostics, and healthcare solutions, catering to various healthcare needs.

3. Strong research and development (R&D): The company invests heavily in R&D, leading to innovative product offerings and technological advancements.

Weaknesses

1. Product recalls: Like any other company in the industry, BD has faced product recall issues in the past, which can dent its reputation and consumer trust.

2. High dependence on key customers: BD relies on a few major customers for a significant portion of its revenue, exposing it to potential revenue fluctuations.

3. Increased competition: The medical technology space is highly competitive, with numerous competitors striving to gain market share.

Opportunities

1. Growing healthcare industry: The healthcare sector's continuous expansion offers opportunities for BD to introduce new products and expand its customer base.

2. Increasing demand for personalized medicine: BD can capitalize on the rising demand for personalized medicine by developing tailored diagnostics and treatment solutions.

3. Emerging markets: Expanding into emerging markets, especially in regions like Asia and Latin America, can provide BD with new avenues for growth.

Threats

1. Stringent regulations: Compliance with stringent regulations and obtaining necessary approvals for new products can pose challenges and delays for BD.

2. Pricing pressures: Intense competition and pricing pressures in the industry can impact BD's profit margins and overall financial performance.

3. Technological advancements: Rapid advancements in medical technology can render existing products obsolete, requiring BD to stay ahead of the curve.

Becton Dickinson and Co Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Becton Dickinson and Co Revenue by Segment

Segmente20172016201520142013
Medical8.11 B USD8.65 B USD6.46 B USD4.57 B USD4.31 B USD
Life Sciences3.99 B USD3.83 B USD3.82 B USD--
Diagnostics---2.71 B USD2.65 B USD
Biosciences---1.16 B USD1.1 B USD

Becton Dickinson and Co Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Becton Dickinson and Co Revenue by Segment

DateAsia PacificEMEAEMEA (a)EuropeGreater AsiaOther (a)Other CountriesOthers CountrySegment Geographical Groups Of Countries Group FourSegment Geographical Groups Of Countries Group ThreeSegment, Geographical, Groups of Countries, Group OneSegment, Geographical, Groups of Countries, Group TwoU.S. PlansUnited States
2023-4.24 B USD--2.91 B USD-8.26 B USD------11.11 B USD
2022-4.04 B USD--3.05 B USD-8.15 B USD------10.72 B USD
2021--4.75 B USD-3.27 B USD1.26 B USD9.28 B USD------10.97 B USD
2020---3.48 B USD2.57 B USD-7.4 B USD------9.72 B USD
2019---3.36 B USD2.73 B USD-1.48 B USD------9.73 B USD
2018---3.3 B USD2.46 B USD-1.46 B USD-----8.77 B USD-
2017---2.59 B USD1.74 B USD-1.26 B USD-----6.5 B USD-
2016---3.05 B USD1.69 B USD-849 M USD------6.89 B USD
2015---2.43 B USD1.55 B USD-1.23 B USD------5.07 B USD
20141.12 B USD--2.73 B USD---1.18 B USD-----3.42 B USD
20131.01 B USD--2.51 B USD---1.18 B USD-----3.35 B USD
2012883.29 M USD--2.38 B USD---1.16 B USD-----3.29 B USD
2011--------1.16 B USD817.32 M USD3.36 B USD2.5 B USD--
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Becton Dickinson and Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Becton Dickinson and Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Becton Dickinson and Co shares outstanding

The number of shares was Becton Dickinson and Co in 2023 — This indicates how many shares 288.392 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Becton Dickinson and Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Becton Dickinson and Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Becton Dickinson and Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Becton Dickinson and Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Becton Dickinson and Co stock splits

In Becton Dickinson and Co's history, there have been no stock splits.
Becton Dickinson and Co does not pay out any dividends.
Becton Dickinson and Co does not pay out any dividends.
Becton Dickinson and Co does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Becton Dickinson and Co.

Becton Dickinson and Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240 0  (0.11 %)2024 Q4
6/30/20240 0  (4.75 %)2024 Q3
3/31/20240 0  (5.7 %)2024 Q2
12/31/20230 0  (10.55 %)2024 Q1
9/30/20230 0  (-1.15 %)2023 Q4
6/30/20230 0  (0.58 %)2023 Q3
3/31/20230 0  (3.21 %)2023 Q2
12/31/20220 0  (10.01 %)2023 Q1
9/30/20220 0  (-0.72 %)2022 Q4
6/30/20220 0  (5.43 %)2022 Q3
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Becton Dickinson and Co stock

Eulerpool World ESG Rating (EESG©)

80/ 100

🌱 Environment

77

👫 Social

95

🏛️ Governance

68

Environment

Scope 1 - Direct Emissions
150,534
Scope 2 - Indirect emissions from purchased energy
442,260
Scope 3 - Indirect emissions within the value chain
6,994,640
Total CO₂ emissions
592,809
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees49
Percentage of women in management
Percentage of Asian employees15
Share of Asian management12
Percentage of Hispanic/Latino employees9
Hispano/Latino Management share18
Percentage of Black employees4
Black Management Share10
Percentage of white employees70
White Management Share58
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Becton Dickinson and Co shareholders

%
Name
Stocks
Change
Date
9.05625 % The Vanguard Group, Inc.26,183,418121,7486/30/2024
5.03436 % BlackRock Institutional Trust Company, N.A.14,555,347-105,4856/30/2024
4.78919 % State Street Global Advisors (US)13,846,500315,5076/30/2024
3.54488 % T. Rowe Price Associates, Inc.10,248,953610,8676/30/2024
2.68236 % T. Rowe Price Investment Management, Inc.7,755,251250,2746/30/2024
2.18064 % Morgan Stanley Investment Management Ltd. (UK)6,304,671-453,1136/30/2024
2.13559 % Geode Capital Management, L.L.C.6,174,412143,4466/30/2024
1.87032 % Generation Investment Management LLP5,407,4732,207,1276/30/2024
1.51699 % MFS Investment Management4,385,91382,2106/30/2024
1.43727 % Columbia Threadneedle Investments (US)4,155,43377,3596/30/2024
1
2
3
4
5
...
10

Becton Dickinson and Co Executives and Management Board

Mr. Thomas Polen

(50)
Becton Dickinson and Co Chairman of the Board, President, Chief Executive Officer (since 2014)
Compensation 17.31 M

Ms. Shana Neal

(58)
Becton Dickinson and Co Chief People Officer, Executive Vice President
Compensation 5.89 M

Mr. Christopher DelOrefice

(52)
Becton Dickinson and Co Chief Financial Officer, Executive Vice President
Compensation 5.21 M

Mr. Michael Garrison

(55)
Becton Dickinson and Co Executive Vice President, President - Medical Segment
Compensation 3.65 M

Mr. David Hickey

(61)
Becton Dickinson and Co Executive Vice President, President - Life Sciences Segment
Compensation 3.35 M
1
2
3
4
...
5

Becton Dickinson and Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Apria, Inc. Stock
Apria, Inc.
SupplierCustomer -0,70-0,340,410,41
Qualigen Therapeutics Stock
Qualigen Therapeutics
SupplierCustomer0,890,550,52-0,62-0,65-0,29
Barnes Group Stock
Barnes Group
SupplierCustomer0,890,650,54-0,14-0,39-0,04
OptimizeRx Stock
OptimizeRx
SupplierCustomer0,850,930,77-0,59-0,560,02
Shenzhen Zhaowei Machinery & Electronic A Stock
Shenzhen Zhaowei Machinery & Electronic A
SupplierCustomer0,840,940,61-0,42-0,28
Shinva Medical Instrument A Stock
Shinva Medical Instrument A
SupplierCustomer0,770,910,570,140,250,26
Thalys Med Tech A Stock
Thalys Med Tech A
SupplierCustomer0,750,910,500,110,33-0,05
Chison Medical Techs A Stock
Chison Medical Techs A
SupplierCustomer0,750,920,68-0,31-0,52-0,18
Maxigen Biotech Inc. Stock
Maxigen Biotech Inc.
SupplierCustomer0,740,650,61-0,62-0,070,25
Ascom Holding Stock
Ascom Holding
SupplierCustomer0,720,890,55-0,40-0,63-0,21
1
2
3

Most common questions regarding Becton Dickinson and Co

What values and corporate philosophy does Becton Dickinson and Co represent?

Becton Dickinson and Co represents a strong commitment to quality and innovation in the healthcare industry. The company's corporate philosophy revolves around improving patient outcomes through advanced medical technologies and solutions. By prioritizing patient safety and healthcare efficiency, Becton Dickinson has established itself as a leading provider of medical devices, diagnostic systems, and pharmaceutical systems. Their values include integrity, collaboration, and customer focus, emphasizing the importance of ethical behavior, teamwork, and meeting customer needs. Becton Dickinson and Co's dedication to advancing healthcare makes it a trusted partner for healthcare professionals worldwide.

In which countries and regions is Becton Dickinson and Co primarily present?

Becton Dickinson and Co is primarily present in numerous countries and regions across the globe. The company operates in various key markets, including the United States, Europe, Asia-Pacific, Latin America, and the Middle East. With its strong global presence, Becton Dickinson and Co has established a solid market foothold, allowing it to cater to a diverse range of customers and meet their healthcare needs effectively.

What significant milestones has the company Becton Dickinson and Co achieved?

Becton Dickinson and Co has achieved several significant milestones throughout its history. The company pioneered the development of the first-ever sterile disposable syringe, which revolutionized healthcare practices worldwide. They also introduced the first medical-grade plastic blood collection tube, improving patient safety and sample integrity. Becton Dickinson and Co expanded its global presence by acquiring C.R. Bard, a leading medical technology company specializing in vascular, urology, and oncology products. This strategic move enhanced their product portfolio and market reach. Furthermore, the company has consistently focused on innovation, manufacturing high-quality medical devices, laboratory equipment, and diagnostic tools. Becton Dickinson and Co continues to drive advancements in healthcare, improving patient outcomes globally.

What is the history and background of the company Becton Dickinson and Co?

Becton Dickinson and Co, commonly known as BD, is a leading global medical technology company. Founded in 1897, BD has a rich history and a strong reputation in the healthcare industry. The company specializes in medical devices, instrument systems, and reagents used by healthcare professionals for diagnostic and therapeutic purposes. With over a century of experience, BD has grown to become a trusted provider of innovative solutions that improve the quality of patient care. Headquartered in Franklin Lakes, New Jersey, BD operates in more than 190 countries worldwide, serving hospitals, laboratories, healthcare professionals, and patients with its diverse portfolio of products.

Who are the main competitors of Becton Dickinson and Co in the market?

The main competitors of Becton Dickinson and Co in the market are Thermo Fisher Scientific Inc., Cardinal Health Inc., and Johnson & Johnson.

In which industries is Becton Dickinson and Co primarily active?

Becton Dickinson and Co is primarily active in the healthcare industry, specifically focusing on medical technology and devices.

What is the business model of Becton Dickinson and Co?

Becton Dickinson and Co (BD) operates under a diversified business model. As a leading global medical technology company, BD focuses on improving healthcare delivery by developing innovative solutions. The company's business model revolves around three main segments: BD Medical, BD Life Sciences, and BD Interventional. BD Medical offers a range of medical devices, such as injection systems and infusion therapy products, to enhance patient care. BD Life Sciences focuses on research and clinical laboratories, providing products for sample management and diagnostics. BD Interventional specializes in devices for minimally invasive procedures, contributing to improved patient outcomes. Becton Dickinson and Co's business model aims to address critical healthcare challenges by delivering reliable and effective solutions.

What is the P/E ratio of Becton Dickinson and Co 2024?

The P/E ratio cannot be calculated for Becton Dickinson and Co at the moment.

What is the P/S ratio of Becton Dickinson and Co 2024?

The P/S cannot be calculated for Becton Dickinson and Co currently.

What is the Quality Investing of Becton Dickinson and Co?

The Quality Investing for Becton Dickinson and Co is 6/10.

What is the revenue of Becton Dickinson and Co 2024?

The revenue cannot currently be calculated for Becton Dickinson and Co.

How high is the profit of Becton Dickinson and Co 2024?

The profit cannot currently be calculated for Becton Dickinson and Co.

What is the business model of Becton Dickinson and Co

Becton Dickinson and Co. (BD) is a global leading medical technology company that specializes in diagnostics, instruments, and systems for medical therapy, laboratories, and life science research. The company is headquartered in New Jersey, USA, and operates in over 190 countries worldwide. The company is divided into three main business segments: BD Medical, BD Life Sciences, and BD Interventional. Each of these segments offers various products and services tailored to the needs of customers in the respective industries. BD Medical specializes in the development, manufacturing, and marketing of medical devices, insulin syringes, needles, and clinical diagnostic instruments. The goal of BD Medical is to help patients improve healthcare and reduce costs through innovative solutions. Some well-known products from BD Medical include BD Vacutainer blood collection systems, BD BACTEC systems for bacterial culture, BD Nexiva Closed I.V. catheter, and BD insulin syringes. BD Life Sciences specializes in the areas of biosciences and research. The company offers a wide range of products and services, including instruments and reagents for molecular biology, infectious diseases, and cancer research. BD Life Sciences supports scientists worldwide in the search for new diagnostic and treatment methods for diseases. Some well-known products from BD Life Sciences include BD FACSFlow Sheath Fluid, BD MAX systems for PCR amplification of DNA and RNA, and BD SurePath vials for cytological diagnosis. BD Interventional offers a variety of products and solutions for interventional medical technology. Key products from BD Interventional include catheters, stents, dilators, guide wires, and implantable devices such as pacemakers and defibrillators. The goal of BD Interventional is to provide surgeons and other medical professionals with the best possible tools and devices to safely and effectively treat patients and minimize the risk of complications. BD is also active in other business segments, such as the oil and gas industry and environmental analysis. The company also offers a wide range of professional services, training, and support to help professionals and customers effectively utilize BD's products and solutions. BD relies on continuous innovation to continuously improve its products and always provide customers with the best quality and performance. The company invests in research and development every year and collaborates closely with medical professionals and scientists to meet the demands of markets and customers. In summary, BD is a leading medical technology company focused on providing innovative products and solutions for the biosciences, clinical diagnostics, interventional medicine, and other industries. The company relies on a wide range of products and services, as well as continuous innovation and collaboration. With its global presence and commitment to quality and performance, BD positions itself as one of the key providers for the medical industry.

What is the Becton Dickinson and Co dividend?

Becton Dickinson and Co pays a dividend of 0 USD distributed over 4 payouts per year.

How often does Becton Dickinson and Co pay dividends?

Becton Dickinson and Co pays out a dividend 4 times a year.

What is the Becton Dickinson and Co ISIN?

The ISIN of Becton Dickinson and Co is US0758871091.

What is the Becton Dickinson and Co WKN?

The WKN of Becton Dickinson and Co is 857675.

What is the Becton Dickinson and Co ticker?

The ticker of Becton Dickinson and Co is BDX.

How much dividend does Becton Dickinson and Co pay?

Over the past 12 months, Becton Dickinson and Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Becton Dickinson and Co is expected to pay a dividend of 3.98 USD.

What is the dividend yield of Becton Dickinson and Co?

The current dividend yield of Becton Dickinson and Co is .

When does Becton Dickinson and Co pay dividends?

Becton Dickinson and Co pays a quarterly dividend. This is distributed in the months of April, July, October, January.

How secure is the dividend of Becton Dickinson and Co?

Becton Dickinson and Co paid dividends every year for the past 54 years.

What is the dividend of Becton Dickinson and Co?

For the upcoming 12 months, dividends amounting to 3.98 USD are expected. This corresponds to a dividend yield of 1.76 %.

In which sector is Becton Dickinson and Co located?

Becton Dickinson and Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Becton Dickinson and Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Becton Dickinson and Co from 12/31/2024 amounting to 1.04 USD, you needed to have the stock in your portfolio before the ex-date on 12/9/2024.

When did Becton Dickinson and Co pay the last dividend?

The last dividend was paid out on 12/31/2024.

What was the dividend of Becton Dickinson and Co in the year 2023?

In the year 2023, Becton Dickinson and Co distributed 3.68 USD as dividends.

In which currency does Becton Dickinson and Co pay out the dividend?

The dividends of Becton Dickinson and Co are distributed in USD.

All fundamentals about Becton Dickinson and Co

Our stock analysis for Becton Dickinson and Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Becton Dickinson and Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.